DE60103546D1 - Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen - Google Patents

Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen

Info

Publication number
DE60103546D1
DE60103546D1 DE60103546T DE60103546T DE60103546D1 DE 60103546 D1 DE60103546 D1 DE 60103546D1 DE 60103546 T DE60103546 T DE 60103546T DE 60103546 T DE60103546 T DE 60103546T DE 60103546 D1 DE60103546 D1 DE 60103546D1
Authority
DE
Germany
Prior art keywords
cluster
preventing
phenyl
alkyl
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60103546T
Other languages
English (en)
Other versions
DE60103546T2 (de
Inventor
E Codd
P Shank
E Rogers
R Plata-Salaman
Boyu Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60103546(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE60103546D1 publication Critical patent/DE60103546D1/de
Application granted granted Critical
Publication of DE60103546T2 publication Critical patent/DE60103546T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60103546T 2000-07-21 2001-07-16 Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen Expired - Lifetime DE60103546T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21965700P 2000-07-21 2000-07-21
US219657P 2000-07-21
PCT/US2001/022322 WO2002007822A2 (en) 2000-07-21 2001-07-16 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Publications (2)

Publication Number Publication Date
DE60103546D1 true DE60103546D1 (de) 2004-07-01
DE60103546T2 DE60103546T2 (de) 2005-06-09

Family

ID=22820176

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103546T Expired - Lifetime DE60103546T2 (de) 2000-07-21 2001-07-16 Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen

Country Status (28)

Country Link
US (4) US20020107283A1 (de)
EP (1) EP1305082B1 (de)
JP (1) JP5271473B2 (de)
KR (1) KR100792814B1 (de)
CN (1) CN1250213C (de)
AT (1) ATE267629T1 (de)
AU (2) AU7349301A (de)
BG (1) BG107529A (de)
BR (1) BR0112713A (de)
CA (1) CA2416819C (de)
CZ (1) CZ2003445A3 (de)
DE (1) DE60103546T2 (de)
DK (1) DK1305082T3 (de)
EA (1) EA005648B1 (de)
ES (1) ES2221651T3 (de)
HU (1) HUP0302940A3 (de)
IL (2) IL154052A0 (de)
MX (1) MXPA03000619A (de)
MY (1) MY127317A (de)
NO (1) NO330055B1 (de)
NZ (1) NZ523851A (de)
PL (1) PL365701A1 (de)
PT (1) PT1305082E (de)
SK (1) SK1962003A3 (de)
TR (1) TR200401511T4 (de)
UA (1) UA74195C2 (de)
WO (1) WO2002007822A2 (de)
ZA (1) ZA200301403B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4276838B2 (ja) 2001-02-27 2009-06-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 疼痛（ｐａｉｎ）の治療における使用のためのカルバメート化合物
HUP0401367A2 (hu) 2001-07-16 2004-12-28 Ortho-Mcneil Pharmaceutical, Inc. Karbamátvegyületek alkalmazása neuropátiás fájdalom, valamint cluster és migrénes fejfájással társuló fájdalom megelőzésére vagy kezelésére
PT1406606E (pt) * 2001-07-16 2007-03-30 Ortho Mcneil Pharm Inc Compostos de carbamato para utilização na prevenção ou tratamento da dor neuropática e da dor associada a cefaleia em salvas e enxaqueca
US20040087642A1 (en) * 2002-10-24 2004-05-06 Zeldis Jerome B. Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
WO2004054608A2 (en) * 2002-12-12 2004-07-01 Agennix Incorporated Lactoferrin in the reduction of pain
US7183381B2 (en) * 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
US7846968B2 (en) * 2005-01-20 2010-12-07 Janssen Pharmaceutica, N.V. Methods for QT interval control
EP2476434A1 (de) 2006-03-30 2012-07-18 GlaxoSmithKline Biologicals S.A. Immunogene Zusammensetzung
US20080194860A1 (en) * 2006-10-10 2008-08-14 Transform Pharmaceuticals, Inc. Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
HU191549B (en) * 1984-04-11 1987-03-30 Richter Gedeon Vegyeszet Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
WO1998055474A1 (fr) * 1997-06-05 1998-12-10 Sanofi-Synthelabo Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique
RU2302240C2 (ru) * 2001-02-27 2007-07-10 Орто-Макнейл Фармасьютикал, Инк. Производные карбаматов для предотвращения или лечения психотических нарушений
CZ20032299A3 (cs) * 2001-02-27 2004-08-18 Ortho@Mcneilápharmaceuticalźáinc Léčivo pro prevenci nebo léčbu motorických poruch
EP1408953B1 (de) * 2001-02-27 2006-04-26 Ortho-Mcneil Pharmaceutical, Inc. Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung

Also Published As

Publication number Publication date
DK1305082T3 (da) 2004-09-13
KR100792814B1 (ko) 2008-01-14
CA2416819A1 (en) 2002-01-31
HUP0302940A3 (en) 2012-02-28
US20020107283A1 (en) 2002-08-08
NO20030299D0 (no) 2003-01-20
NO20030299L (no) 2003-03-12
MY127317A (en) 2006-11-30
WO2002007822A2 (en) 2002-01-31
US20090281179A1 (en) 2009-11-12
HUP0302940A2 (hu) 2003-12-29
ES2221651T3 (es) 2005-01-01
AU2001273493B2 (en) 2005-08-11
CA2416819C (en) 2011-03-22
NZ523851A (en) 2004-09-24
ATE267629T1 (de) 2004-06-15
WO2002007822A3 (en) 2002-05-30
IL154052A (en) 2008-07-08
EP1305082B1 (de) 2004-05-26
JP5271473B2 (ja) 2013-08-21
AU7349301A (en) 2002-02-05
JP2004504362A (ja) 2004-02-12
PL365701A1 (en) 2005-01-10
NO330055B1 (no) 2011-02-14
DE60103546T2 (de) 2005-06-09
BR0112713A (pt) 2003-07-22
BG107529A (bg) 2003-09-30
KR20030022300A (ko) 2003-03-15
US20060183795A1 (en) 2006-08-17
US20040266866A1 (en) 2004-12-30
CN1250213C (zh) 2006-04-12
ZA200301403B (en) 2004-06-15
CN1458853A (zh) 2003-11-26
PT1305082E (pt) 2004-09-30
IL154052A0 (en) 2003-07-31
UA74195C2 (uk) 2005-11-15
MXPA03000619A (es) 2004-07-30
EA005648B1 (ru) 2005-04-28
EP1305082A2 (de) 2003-05-02
EA200300042A1 (ru) 2003-06-26
SK1962003A3 (en) 2004-08-03
TR200401511T4 (tr) 2004-08-23
CZ2003445A3 (cs) 2004-08-18

Similar Documents

Publication Publication Date Title
ATE378046T1 (de) Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen
DE60103546D1 (de) Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen
HK1063436A1 (en) Carbamate compounds for use in preventing or trea ting bipolar disorder
ATE324107T1 (de) Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
ATE435014T1 (de) Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
HK1063288A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN